Beckman Coulter Closes $235M Offering; Will Pay Off Debt Tied to Lumigen Buy | GenomeWeb
NEW YORK (GenomeWeb News) — Beckman Coulter closed its tender offer for $235 million in senior notes at the end of business yesterday, the company said today.
 
The company said the money raised from the offering would go toward paying debts, a large chunk of which coming from the acquisition of Lumigen, and it would use the rest of the funds to pay debts and fund research.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.